Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05914298
Other study ID # 0012479
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2018
Est. completion date February 1, 2022

Study information

Verified date June 2023
Source Istituto Ortopedico Rizzoli
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

the purpose of the present registry is to describe the epidemiology of forearm deformities in patients with Hereditary Multiple Exostoses and to identify, independent predictors of severity of the disease and potential association with genotypic patterns


Description:

Hereditary Multiple Exostoses (HME) is a rare pediatric autosomal dominant disorder caused by loss-of-function mutations in the genes encoding the heparan sulfate (HS)-synthesizing enzymes EXT1 or EXT2. HME affects 1 in 50,000 people and has 100% penetrance but great variability in phenotypic expression. HME is characterized by formation of cartilaginous outgrowths, called osteochondromas or exostoses, next to the growth plates of many axial and appendicular skeletal elements, causing multiple, painful disfiguring and disabling skeletal deformities, and potential malignant transformation into peripherral chondrosarcoma. The involvement of upper-limb bones by HME is associated with greater loss of function than elsewhere in the body, but even here the loss of function may be limited. Moreover, the constant relationship between height and ulnar length has long been recognized in forensic medicine and has been recently analyzed also in HME, in order to predict the clinical and functional outcomes of the upper limb. the present registry aims to collect demographic, clinical, functional and radiographic information from patients with HME in order to establish phenotypic predictors of severity of the disease and potential association with genotypic patterns


Recruitment information / eligibility

Status Completed
Enrollment 408
Est. completion date February 1, 2022
Est. primary completion date February 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - patients with HME (> 2 exostoses) Exclusion Criteria: - Patients with solitary exostoses - Patients, adults or minors, who are unable to give their timely informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
blood and buccal swab genetic test
blood samples and buccal swabs will be obtained from patients with HME in order to analyze the genotype (EXT1 or EXT2 mutations) and correlate the genotypic pattern with the phenotypic presentation
PUL
measurement of ulnar length with anthropometer and patient's height
Range of motion
measurement of range of motion of elbow, forearm and wrist

Locations

Country Name City State
Italy Manila Boarini Bologna

Sponsors (1)

Lead Sponsor Collaborator
Istituto Ortopedico Rizzoli

Country where clinical trial is conducted

Italy, 

References & Publications (4)

Clement ND, Porter DE. Forearm deformity in patients with hereditary multiple exostoses: factors associated with range of motion and radial head dislocation. J Bone Joint Surg Am. 2013 Sep 4;95(17):1586-92. doi: 10.2106/JBJS.L.00736. — View Citation

Mordenti M, Ferrari E, Pedrini E, Fabbri N, Campanacci L, Muselli M, Sangiorgi L. Validation of a new multiple osteochondromas classification through Switching Neural Networks. Am J Med Genet A. 2013 Mar;161A(3):556-60. doi: 10.1002/ajmg.a.35819. Epub 201 — View Citation

Pedrini E, De Luca A, Valente EM, Maini V, Capponcelli S, Mordenti M, Mingarelli R, Sangiorgi L, Dallapiccola B. Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas. Hum Mutat. 2005 Sep;26(3):280. doi: 10.10 — View Citation

Pedrini E, Jennes I, Tremosini M, Milanesi A, Mordenti M, Parra A, Sgariglia F, Zuntini M, Campanacci L, Fabbri N, Pignotti E, Wuyts W, Sangiorgi L. Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: identification of — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary proportional ulnar length (PUL) proportional ulnar length (PUL) is the ratio between ulnar lenght and the height of the patient 1 year
Secondary genotype identify potential association among the genotypic pattern (EXT1 or EXT2) and phenotypic presentation 1 year
Secondary forearm function elbow, forearm and wrist range of motion (ROM) measured by a goneometer 1 year
Secondary EuroQol 5D EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group 1 year
See also
  Status Clinical Trial Phase
Completed NCT00474448 - The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses
Terminated NCT03442985 - An Efficacy and Safety Study of Palovarotene for the Treatment of MO Phase 2
Suspended NCT00474331 - Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project
Terminated NCT00473850 - Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC N/A

External Links